Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes

Biotherapy. 1990;2(3):247-59. doi: 10.1007/BF02173526.

Abstract

The tumor-infiltrating lymphocytes (TILs) were cultured with interleukin 2 (IL-2) to induce the activated killer cells possessing autologous tumor-killing activity, and analysed their cell surface phenotypes and assessed anti-tumor killing activity. Furthermore, the activated TILs were transferred into 7 patients adoptively resulting in complete remission in a patient with pancreatic cancer and partial remission in another patient with gastric cancer. The cytotoxic activities of activated TILs at 3 weeks-incubation was 72 +/- 15, 42 +/- 26, 27 +/- 21 and 25 +/- 15% against K562, Daudi, KATO-III and autologous tumor, respectively. The negative selection method, indicated that the killer cells recognizing autologous tumor cells consisted of CD4- or CD8-positive T lymphocytes and CD16- or CD56-positive natural killer cells. The activated TILs could not only lyse cultured tumor cell lines, but also autologous tumor cells.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Antigens, Differentiation, T-Lymphocyte / immunology
  • CD56 Antigen
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Immunotherapy, Adoptive
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / pharmacology
  • Killer Cells, Lymphokine-Activated / immunology
  • Killer Cells, Lymphokine-Activated / physiology
  • Lymphocyte Activation / drug effects
  • Lymphocytes, Tumor-Infiltrating / drug effects
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / physiology*
  • Male
  • Middle Aged
  • Neoplasms / therapy
  • Phenotype
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Cytotoxic / physiology

Substances

  • Antigens, Differentiation, T-Lymphocyte
  • CD56 Antigen
  • Interleukin-2